Hims & Hers is shutting down Apostrophe, the skincare company it acquired in 2021, after a tumultuous month for the public ...

A company spokesperson said the ad was a "direct response" the Hims & Hers Super Bowl commercial. The ad features a vial that reads "compounded semaglutide" and a syringe. "Some compounded ...

Before Hims & Hers' commercial even aired, Democratic Sen. Dick Durbin of Illinois and Republican Sen. Roger Marshall of Kansas sent a letter to the FDA asking the agency to take action for what ...

“The recent explosion in irresponsible and misleading advertising about compounded GLP-1 (glucagon-like peptide-1) drugs, like the Hims & Hers Super Bowl commercial, puts patients’ safety at ...

The GLP-1 wars are heating up. After telehealth brand Hims & Hers aired its first Super Bowl commercial Sunday night, competitor Novo Nordisk, which makes competing weight loss drugs Ozempic and ...

Hims & Hers Health reported fourth-quarter results on Monday that beat analysts’ expectations, but the stock sank in extended trading.

Hims & Hers saw a massive YTD surge, but FDA news led to a pullback. Find out why HIMS stock is still undervalued and why ...

BofA analyst Allen Lutz notes that the Food and Drug Administration yesterday provided updated enforcement timelines for semaglutide and ...

Hims & Hers Health shares were headed for their biggest single-day plunge as Wall Street analysts questioned the telehealth provider's lofty sales forecast on Tuesday amid looming restrictions on ...

Telehealth company Hims & Hers Health (HIMS) witnessed a major dip in its stock recently despite reporting 95% revenue growth ...